11 November 2019
Nuffield Department of Clinical Neuroscience’s Associate Professor Andrea Nemeth is leading the Oxford part of a gene therapy trial for Hungtinton’s disease.
22 July 2019
A large clinical trial in Africa and Asia has shown that a 7 day course of high dose primaquine, a drug used to treat P. vivax malaria, is well tolerated and just as effective as the current standard 14 day regimen, according to a study published this week in The Lancet. These findings have important implications for the treatment and elimination of vivax malaria in the Asia Pacific.
11 March 2019
High levels of cholesterol are a major risk factor for stroke according to new research published today in Nature Medicine by researchers in Nuffield Department of Population Health.
18 July 2018
Oxford University Hospitals NHS Foundation Trust has risen to the top of a table for the most patients recruited to take part in research studies.
12 April 2018
NewKI, one of UK’s largest observational studies of incident chronic kidney disease (CKD) in general practice, gets underway this month, involving 3,205 Oxfordshire residents and led by Oxford University researchers.
28 March 2018
Researchers are working with schools around the county to find 24,000 volunteers aged 16 to 18 years to take part in the Be on the TEAM (Teenagers Against Meningitis) trial, led by the Oxford Vaccine Group at the Oxford University's Paediatrics Department with funding and support from the National Institute for Health Research (NIHR).
28 July 2017
PREGNANT women receiving antenatal care at the John Radcliffe Hospital are being invited to take part in a world-first clinical trial.
6 February 2017
Researchers from the University of Oxford are collaborating with the Japanese pharmaceutical company, SBI Pharmaceuticals, to minimise deterioration of heart function outcomes after cardiac surgery.
19 December 2016
Circadian Therapeutics, a life sciences spinout of Oxford University, has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
6 December 2016
Oxford Biodynamics, a biomarker company set up by former Dunn School researchers Dr Alexandre Akoulitchev and Dr Aroul Ramadass, completed a successful flotation on AIM, the London Stock Exchange’s international market for smaller growing companies, on 6 December 2016.
1 November 2016
The number of medical research studies at Oxford University Hospitals NHS Foundation Trust has hit a record high, new figures show.
31 October 2016
Evidence suggests hundreds of babies develop a serious bowel problem called necrotising enterocolitis (NEC) each year in the UK.
uMotif and Oxford University Innovation collaborate on world’s largest health tracking study to improve the lives of those with Parkinson’s
5 October 2016
One person in every 500 has Parkinson’s disease, with more than 127,000 people in the UK and around 10 million people globally diagnosed with the condition. A unique global health project – 100 for Parkinson’s - has engaged thousands of people across the world to track their health, using smartphone technology, to provide valuable new insights on the impact of Parkinson’s on their daily lives.
21 August 2016
A new multimillion pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer's disease ever performed on volunteers, is announced today (Monday 22 August).